Will the launch of Favipiravir mark the turnaround for Glenmark Pharma?

If the drug proves to be efficacious for Covid treatment, Glenmark
will enjoy first mover advantage.

https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/will-the-launch-of-favipiravir-mark-the-turnaround-for-glenmark-pharma/articleshow/76498905.cms

Comments

Popular posts from this blog

TIGS-CI Biological Sciences Research Assistant Recruitment, Apply Online

Biotecnika Times Newsletter 30.11.2021 CSIR-IGIB Rs 1.5 Lakh pm Pay Job, ACTREC High Pay

Biotecnika Times Newsletter 25.10.2021 Tata Innovation Fellowship 2021, NCCS PhD Admission